FSSAI issues notices to Nestle India, Zydus Wellness
In short
FSSAI said it has sent notices to Nestle India and Zydus Wellness. The notices concern claims on Lactogen Pro 1, Nan Excella Pro Stage 1, and Complan, and the regulator wants scientific proof.
This matters because the companies may have to defend their product claims. It is not clear yet whether FSSAI will take further action or impose any penalty.
What the reporting says
FSSAI said it issued notices to Nestle India over alleged misleading claims and non-compliant promotions involving Lactogen Pro 1 Powder and Nan Excella Pro Stage 1, while Zydus Wellness also received a notice over Complan. The regulator said it wants scientific evidence for the claims, and Zydus said its claims are factual and backed by science. The available reporting does not state any penalties or final findings.
Why it matters
FSSAI said it issued notices to Nestle India over alleged misleading claims and non-compliant promotions for Lactogen Pro 1 Powder and Nan Excella Pro Stage 1, and Zydus Wellness also received a notice over Complan. The regulator has sought scientific evidence, while Zydus said its claims are factual and science-backed. The available reporting does not state any enforcement outcome, deadline or penalty.